RE:RE:RE:RE:RE:RE:RE:New Analyst Coverage: Thera "Speculative Buy"I believe in decency and honesty and I don't suggest THTX to engage in any dubious activities, my point is their strategy to support the valuation hasn't changed despite the arrival of the new CEO.
Let's face it the execution has been slow , the communication is confusing thus far.
If you really want to get the SP to appreciate you have to start at right end which is the retail, get the attention of mom and dad investors, therefore they need to engage with the average investor earn their trust, increase the demand/daily volume then go after institutional investors.
They first announced HIV NASH opportunity a year and half ago, last September they announced the shift to general NASH which was supposed to be submitted in few weeks and then radio silence!
nothing more than it will be submitted by end of the year as per IP.
point is they need to be more precise and stop hiding behind words such as few weeks/imminent also they need to speed up as the progress has been far to slow, I get it they need to perfect the applications in order to enhance the success rate but while the competitors are progressing THTX has been far to slow.
I still struggle to understand why they don't think submission of both protocols is not material event for this company, maybe that is true for other companies with great track record but THTX needs to come out of hiding and market their programs in a proper manner so we get those investors which are not convinced atm.